Delivery Order SPE2DR25D3109-SPE2DR26FT2NB
- Not listed
- The Defense Logistics Agency awarded a $8,745.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 5 mg/0.5 ml pens. The contract, which has no set-aside designation, is scheduled for completion by December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,359.38 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on November 26, 2025, with completion expected by November 28, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,340.16 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,754.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and was awarded on a competitive, non-set-aside basis. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $15,858.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price contract, which is not set-aside, will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $9,854.88 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $15,743.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's broader pharmaceutical support framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense...
- The Defense Logistics Agency awarded a delivery order valued at approximately $10,028 to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Zepbound 10 mg/0.5 ml pens with an ultimate completion date of January 12, 2026. This non-set-aside, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,812.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on January 14, 2026. This is a firm fixed-price, non-set-aside delivery order with a completion date of January 15, 2026, to be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT2NBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,850.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on January 14, 2026, with an ultimate completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (which operates under the AmerisourceBergen name), a major pharmaceutical distributor serving federal healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Zepbound, a diabetes medication, represents one of many pharmaceutical products the contractor delivers through this vehicle to support military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 1/13/26 |